Pierre‐Auguste Petignat
About
In The Last Decade
Pierre‐Auguste Petignat
16 papers receiving 193 citations
Peers
Comparison fields: 5 of 52
- Epidemiology 147
- Emergency Medicine 47
- Critical Care and Intensive Care Medicine 45
- Pharmacology 25
- Pulmonary and Respiratory Medicine 23
Countries citing papers authored by Pierre‐Auguste Petignat
This map shows the geographic impact of Pierre‐Auguste Petignat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐Auguste Petignat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐Auguste Petignat more than expected).
Fields of papers citing papers by Pierre‐Auguste Petignat
This network shows the impact of papers produced by Pierre‐Auguste Petignat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐Auguste Petignat. The network helps show where Pierre‐Auguste Petignat may publish in the future.
Co-authorship network of co-authors of Pierre‐Auguste Petignat
This figure shows the co-authorship network connecting the top 25 collaborators of Pierre‐Auguste Petignat. A scholar is included among the top collaborators of Pierre‐Auguste Petignat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre‐Auguste Petignat. Pierre‐Auguste Petignat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | [Cephalosporins in clinical practice]. | 2 |
| 5 | 1 | |
| 6 | [Renal toxicities in oncology therapies]. | 1 |
| 7 | 2 | |
| 8 | [Direct oral anticoagulants : some practical considerations]. | 1 |
| 9 | 8 | |
| 10 | 3 | |
| 11 | 155 | |
| 12 | [Steroid-induced hyperglycemia, a common clinical problem in medicine without evidence-based guidelines]. | 3 |
| 13 | 0 | |
| 14 | 1 | |
| 15 | [Are the guidelines the standards we have to follow]. | 1 |
| 16 | 1 | |
| 17 | [Analgesia and renal insufficiency]. | 3 |
| 18 | 2 | |
| 19 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.